Pediatric Central Venous Access Device Lock Solutions: A Network Meta-analysis

Pediatrics. 2024 Jan 1;153(2):e2023063264. doi: 10.1542/peds.2023-063264.

Abstract

Context: Central venous access device (CVAD) locks are routine interventions used to prevent and treat complications, such as infection, thrombosis, and catheter occlusion.

Objective: To compare and rank lock-solutions for prevention or treatment of complications in pediatrics. Design Systematic review and network meta-analysis.

Data sources: Five databases and 2 clinical trial registries were searched.

Study selection: Published and unpublished randomized controlled trials that enrolled pediatric patients with a CVAD and compared the effectiveness of lock-solutions.

Data extraction: Data extraction was conducted by 2 reviewers. Odds ratio (OR) for prevention or treatment of CVAD-associated bloodstream infection (BSI), thrombosis, occlusion, CVAD-failure, and mortality were calculated, with point estimates ranking lock-solutions.

Results: Twenty-nine studies were included. Chelating agents and antibiotic locks given as prevention were associated with lower odds (OR: 0.11; 95% confidence interval [CI]: 0.02-0.67; moderate-quality; OR: 0.19; 95% CI: 0.05-0.79, high-quality, respectively) of CVAD-associated BSI compared with heparinized saline (reference). Preventative thrombolytic agents had lower odds (OR: 0.64, 95% CI: 0.44-0.93; low-quality) of CVAD occlusion, whereas ethanol had higher odds (OR: 2.84, 95% CI: 1.31-6.16; high-quality) compared with heparinized saline (reference). No lock solution had effects on thrombosis prevention or treatment, CVAD-failure, CVAD-associated BSI treatment failure, or mortality.

Limitations: There was substantial uncertainty around the point estimates because of the limited number of studies for outcomes and study heterogeneity. More high-quality studies are needed to confirm the efficacy of lock solutions.

Conclusions: Chelating agents and antibiotic locks may be effective for CVAD-associated BSI prevention in pediatrics. Thrombolytic agents can be an option for CVAD occlusion prevention, whereas ethanol may not be recommended.

Publication types

  • Meta-Analysis

MeSH terms

  • Anti-Bacterial Agents
  • Catheter-Related Infections* / prevention & control
  • Catheterization, Central Venous* / adverse effects
  • Central Venous Catheters* / adverse effects
  • Chelating Agents
  • Child
  • Ethanol
  • Fibrinolytic Agents
  • Humans
  • Network Meta-Analysis
  • Sepsis*
  • Thrombosis* / etiology
  • Thrombosis* / prevention & control

Substances

  • Fibrinolytic Agents
  • Anti-Bacterial Agents
  • Ethanol
  • Chelating Agents